Macerich Co (MAC) is not a strong buy at the moment for a beginner investor with a long-term horizon. While there are some positive catalysts like analyst upgrades and potential benefits from the 'Path Forward Plan,' the company's weak financial performance and lack of significant trading signals make it prudent to hold off on investing right now.
The technical indicators show mixed signals. The MACD is positive but contracting, RSI is neutral at 53.686, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels indicate a pivot at 21.714 with resistance at 22.321 and support at 21.107. The stock has a 60% chance of a slight decline in the next day and week but a potential 4.48% gain in the next month.

Analyst upgrades from Scotiabank and KeyBanc with price targets of $22 and $25, respectively, citing the company's 'Path Forward Plan' and improving operating income growth.
Bullish moving averages and potential for a 4.48% gain in the next month.
Weak financial performance in Q4 2025, with revenue down 4.37% YoY, net income down 91.04% YoY, and EPS down 92.13% YoY.
Lack of recent news or significant trading activity from hedge funds, insiders, or Congress.
No strong trading signals from AI Stock Picker or SwingMax.
The company's Q4 2025 financials show significant declines: Revenue dropped to $261.7M (-4.37% YoY), Net Income dropped to -$18.95M (-91.04% YoY), EPS dropped to -0.07 (-92.13% YoY), and Gross Margin dropped to 22.57% (-10.72% YoY).
Analyst sentiment is mixed but improving. Scotiabank upgraded the stock to Outperform with a $22 price target, and KeyBanc upgraded it to Overweight with a $25 price target. However, JPMorgan and Goldman Sachs maintain cautious views with Underweight and Sell ratings, respectively.